Two Regimens for Patients with Non-small Cell Lung Cancer
A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy.
Patients with unresectable non-small cell lung cancer (NSCLC) can be subdivided into three treatment groups. The first includes those with good performance status (PS) with locally advanced disease (T1–2N2M0 or T3–4N0–3M0) that can be treated with radical chemoradiation therapy (CRT): i.e., a radiation dose of at least 60 Gy with concurrent platinum chemotherapy doublet. The second includes patients with stage I–IIIB poor PS and all stage IV advanced disease who are treated with local or general palliative symptom measures or systemic chemotherapy based on their PS and their symptom nature...
Click below to read the full research report:
Trans Tasman Radiation Oncology Study TROG 03.07